Universidad de la Sabana Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Alternative names

Universiad de La Sabana | Universidad de la Sabana

Active Ingredients

Drugs in Other Trials (1)

wharton's jelly mesenchymal stem cells (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1